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Optic nerveAxon regeneration in themature central nervous system is limited by extrinsic inhibitory signals and a postnatal
decline in neurons' intrinsic growth capacity. Neuronal levels of the second messenger cAMP are important in
regulating both intrinsic growth capacity and neurons' responses to extrinsic factors. Approacheswhich increase
intracellular cAMP in neurons enhance neurite outgrowth and facilitate regeneration after injury. Thus, under-
standing the factors which affect cAMP in neurons is of potential therapeutic importance. Recently, soluble
adenylyl cyclase (sAC, ADCY10), the ubiquitous, non-transmembrane adenylyl cyclase, was found to play a key
role in neuronal survival and axon growth. sAC is activated by bicarbonate and cations and may translate phys-
iologic signals frommetabolism and electrical activity into a neuron's decision to survive or regenerate. Here we
critically review the literature surrounding sAC and cAMP signaling in neurons to further elucidate the potential
role of sAC signaling in neurite outgrowth and regeneration. This article is part of a Special Issue entitled: The role
of soluble adenylyl cyclase in health and disease.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Unlike immature neurons that demonstrate a robust capacity to
regenerate, adult mammalian central nervous system (CNS) neurons
fail to regenerate in response to injury [1,2]. Failed adult regeneration
can be attributed to both intrinsic and extrinsic factors. In the adult
CNS, injury results in the release or deposition of inhibitory molecules
within myelin [3–6] and the glial scar [7–9]. A relative insufﬁciency of
neurotrophic signaling also contributes [10]. Additionally, neurons
decrease in their intrinsic growth capacity as a function of maturity, as
reﬂected by a postnatal decline in ability for rapid neurite extension
[11].While simply blocking the expression or presentation of glial-asso-
ciated inhibitory factors can promote axonal regeneration after injury
[6,8], the relative ability of immature neurons to overcome inhibitory
cues [12–14] suggests that therapeutic targeting of the factors that
inﬂuence the intrinsic growth state of the neuron may be effective in
regenerative medicine.
Levels of the second messenger adenosine 3′-5′-cyclic mono-
phosphate (cAMP) correlate with intrinsic neurite outgrowth capacity
of neurons [15]. The effect of cAMP on neurite outgrowth was ﬁrst
demonstrated in chick dorsal root ganglia cells, in which cAMP treat-
ment increased both length and number of axons [16]. Since then, the
role of cAMP in the growth and guidance of axons has been extensively
studied. As neurons mature, intracellular cAMP levels decline alonge of soluble adenylyl cyclase in
).with the ability of axons to regenerate after injury [15,17]. In mature
neurons, increasing cAMP reverses this effect, and attenuates inhibitory
signaling derived from molecules in CNS myelin and the glial scar [18].
Understanding the mechanisms underlying cAMP production may be
vital for the development of therapeutic strategies to address regenera-
tive failure in CNS injury. In this reviewwewill discuss soluble adenylyl
cyclase (sAC), a member of the adenylyl cyclase (AC) family that has
recently been recognized as a potent regulator of neurite outgrowth
and neuronal survival [19].
2. cAMP in neurite outgrowth
The induction of neurite outgrowth by cAMP can be divided into 2
phases, the ﬁrst acting at the growth cone/axonal tip and the second
at the cell body and nucleus, inducing transcriptional changes that
sustain neurite outgrowth [20,21]. Growth cones are a specialized
form of lamellipodia responsible for guiding and exerting tension on
the trailing axon [22]. At the growth cone, cAMP-mediated activation
of protein kinase A (PKA) causes inactivation of the small G-protein
Rho, which results in potentiation of neurite outgrowth [14]. While
growth cone dynamics are important for proper axonal guidance and
motility, their activities are largely independent from neurite assembly
[23]. The ability of cAMP to inﬂuence growth cone directionality was
ﬁrst observed in experiments utilizing extracellular, cell-permeable,
cAMP gradients, which induced turning and directional attraction of
growth cones [24]. When a gradient of cell-permeable cAMP was
replaced with a bath application, modulation of responses to other
signaling molecules (see below) was observed [25]. In some cases,
axons were even found to exhibit opposite reactions to guidance cues
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signaling in the intrinsic regulation of neuronal growth responses [26].
What are the cues being modulated by cAMP and how does cAMP
exert these effects? Paracrine factors are critical for the proper guidance
and development of neurons. One family of structurally related mole-
cules referred to as neurotrophins has been widely studied and is
involved in a variety of neuronal functions [27]. The ﬁrst discovered
neurotrophin was nerve growth factor (NGF) [28]. While NGF was the
ﬁrst discovered, and arguably most heavily studied neurotrophin, it
may not be the best surrogate from which to infer a role for cAMP in
neurotrophin signaling. Only a select few neuronal subtypes respond
toNGF, indicating that the neurotrophic effects for this speciﬁcmolecule
may be unique and/or highly specialized [29]. Other well-characterized
neurotrophins include brain-derived neurotrophic factor (BDNF),
neurotrophin-3 (NT-3), and neurotrophin-4/5 (NT-4/5) [27,30]. Like
NGF, other neurotrophins induce survival and neurite growth in
various, often speciﬁc neuronal subtypes. All neurotrophins bind to a
sub-family of receptor tyrosine kinases (RTKs) known as tropomyosin
receptor kinase (Trk) receptors [31], in addition to binding with a
lower afﬁnity to the tumor necrosis alpha-receptor (TNFR) familymem-
ber p75 [32]. While all neurotrophins bind p75, they differentially bind
to for individual Trk receptors. TrkA is speciﬁc for NGF, TrkB binds both
BDNF and NT4/5, and TrkC binds NT3 [33]. Activation of Trk receptors is
similarly sufﬁcient to promote survival and neurite growth [34,35].
BDNF activation of TrkB, as well as the trafﬁcking of this receptor, is
cAMP-dependent [36]. In contrast, NGF-mediated and NT-3-mediated
phosphorylation of TrkA and TrkC, respectively, do not require cAMP.
This is intriguing as NGF and NT-3 have considerably weaker capacity
to promote survival or regeneration in retinal ganglion cells [37],
while both neurotrophin ligands of TrkB (BDNF and NT-4/5) demon-
strate beneﬁt in both regards [38]. Additionally, ‘priming’ neurons via
pre-treatment with BDNF overcome inhibitory cues in CNS myelin in a
cAMP-dependent manner [39,40]. The ability of TrkB ligands to modify
regenerative capacity is consistent with the theory that cAMP is impor-
tant in mediating growth and regenerative capacity of neurons.
Other signaling ligands similarly promote neurite growth, albeit
through different signaling pathways. For example, pituitary adenylyl
cyclase-activating peptide (PACAP) demonstrates similar neurite out-
growth promotion as NGF in PC12 cells [41] and also promotes neurite
outgrowth and survival in primary neurons [42–44]. PACAP exerts these
effects via activation of transmembrane ACs (tmACs) which associate
with the PACAP receptor, PAC1 [41]. PACAP and NGF both activate the
small GTP-binding protein Rap1, which leads to sustained activation of
ERK mitogen-activated protein kinase, which is required for neurite
outgrowth [41,45–48]. NGF activation of Rap1 has been suggested to
be dependent on protein kinase A (PKA) activation, which requires
cAMP [45,46], albeit whether NGF-dependent neurite extension is
cAMP-dependent is controversial [49]. However, synergistic effects of
cAMP and NGF on signaling and neurite outgrowth have been observed
[50], and NGF-dependent neurite outgrowth is not supported when
NGF is replaced by cAMP [51], which conﬁrms that distinct signaling
pathways exist for NGF and cAMP.
The role of cAMP in the nucleus-mediated promotion of neurite out-
growth has beenmost closely tied to phosphorylation of cAMP response
element binding protein (CREB) [52,53]. Increased intracellular cAMP
leads to phosphorylation of CREB,which is critical for the transcriptional
programs needed for neuritogenesis [54]. Constitutively activated CREB
results in robust neurite outgrowth and attenuated responsiveness to
CNS molecules which inhibit regeneration [53]. Interestingly, these ef-
fects mirror the response of neurons pre-treated with exogenous
BDNF and/or cAMP [18,53].
Besides neurotrophin stimulation, neuronal activity is beneﬁcial for
both neuronal survival and proper guidance and innervation during de-
velopment [19,55,56]. In the eye, spontaneous retinal activity is
required for proper development, and this spontaneous activity results
in increased intracellular calcium and cAMP [57]. Such calciumtransients are known to affect in vivo axon extension and pathﬁnding
[58]. Damaged mature neurons have both decreased spontaneous elec-
trical activity and decreased cAMP and calcium inﬂux. The correlation
between spontaneous activity of immature neurons and calcium/
cAMP levels further supports the importance of cAMP signaling as a
therapeutic target for CNS regeneration.
3. How is cAMP produced?
Adenylyl cyclases (ACs) are the family of enzymes that synthesize
cAMP. There are 9 mammalian transmembrane ACs (tmACs) that are
activated by G-protein coupled receptors (GPCRs). While all tmACs
are activated by Gsα, these tmACs are differentially regulated by Gβγ,
protein kinase phosphorylation and calcium. In addition to signaling
in response to extracellular stimuli at the plasma membrane, tmACs
also can continue cAMP production even after clearance from the plas-
ma membrane associated with uptake and trafﬁcking of membrane-
derived endosomes [59,60]. In contrast, sAC (ACDY10) is unique
among the ACs in lacking transmembrane domains, insensitivity to G-
proteins, and bicarbonate-mediated activation, in addition to being acti-
vated by calcium. While sAC is most readily detectable in the testis
where it has a role in sperm maturation [61], bicarbonate-stimulated
cAMP production has been observed in most other tissues and is
thought to be associatedwith intracellular organelles like themitochon-
drion and the nucleus [62]. Due to ubiquitous carbonic anhydrases, in-
tracellular pH affects bicarbonate levels that in turn directly modulate
sAC activity (Fig. 1) [63]. As mentioned above, sAC is also activated by
divalent cations such as calcium [64], via an independent mechanism
that can be synergistic with bicarbonate [65].
cAMP and tmAC function have classically been studied using
forskolin, a potent pharmacologic activator of all tmACs except AC9
[66,67]. sAC is also insensitive to direct stimulation by forskolin [68].
Elucidating the individual functions of different ACs has been hindered
by a lack of useful antibodies for the different ACs, as well as a lack of
speciﬁc inhibitors [54,69,70]. KH7 is an inhibitor that shows selectivity
for sAC and has been used in conjunction with RNA interference
(RNAi) to demonstrate sAC-speciﬁc functions [71]. Recently, knock-
out mice for individual ACs, including sAC, have become available that
should allow assignment of speciﬁc cyclase functions.
4. Soluble adenylyl cyclase
The ﬁrst reported observation of a “soluble” AC with no transmem-
brane associationwas in 1975 [72]. Over 2 decades later the puriﬁcation
and cloning of sAC was reported [73]. The newly discovered sAC cDNA
encoded a 187-kDa protein containing 2 catalytic domains (C1 and
C2) that demonstrated similarity to AC domains from different
cyanobacterial species, suggesting that the sAC catalytic domains
evolved as a fusion of 2 distinct bacterial cyclases [73]. The
cyanobacterial ACs also demonstrate bicarbonate sensitivity, again
supporting an evolutionarily conserved bicarbonate-mediated activi-
ty [61,73]. This conﬁrmation of a mammalian, bicarbonate-sensitive
AC provided a vital insight into the mechanisms underlying
bicarbonate-induced spermatozoa competence and other tmAC-
independent, cAMP-mediated cellular events [74–77].
Human sAC is the product of the ADCY10 gene,which is N100 kb and
is comprised of N33 exons [64]. While there is a single mammalian sAC
gene, there are a number of different sACmRNAs that have been identi-
ﬁed by PCR from various cell types. These isoforms are consistent with
ADCY10 mRNA alternative RNA splicing and promoter usage [78,79].
However, validation of the existence of these various sAC isoforms has
been difﬁcult due to an inability to reliably detect sAC protein by west-
ern blotting in tissues other than the testes. The original puriﬁcation of
sAC from the testis in both rat and human also revealed an abundant,
functional 48 kDa protein [80,81]. This smaller sAC may be a cleavage
product of the larger 187-kDa protein, although an alternatively-
Fig. 1. sAC associates withmitochondria and responds to decreasing pH via bicarbonate activation. Increases in carbon dioxide (CO2) resulting frommetabolic energy production result in
decreased pH due to the ubiquitous presence of carbonic anhydrase (CA) which converts CO2 into bicarbonate (HCO3), which in turn activates sAC.
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[73,78]. This N-terminal, catalytically-active fragment of full-length
sAC contains the 2 catalytic domains [82]. C-terminal to the C2 domain
in full-length testes sAC is a putative auto-inhibitory region [83] and
canonical p-loop and leucine zipper motifs [73]. While the p-loop of
the C-terminal domain of sAC is dispensable for catalytic activity, this
region of sAC which is not present in tmACs may allow sAC to function
uniquely as a cellular ATP sensor [65,73,83]. In general, the function of
the long C-terminal tail of full-length remains unknown, but could func-
tion to target sAC via protein–protein interactions to speciﬁc intracellu-
lar sites of action.
sAC function has been studied in vivo using knock-outmice. Theﬁrst
mouse model used to study sAC function was a deletion in the 2nd–4th
exons encoding the C1 catalytic domain, resulting in infertility due to
dysfunctional sperm and dyslipidemia [79,83,84]. In these animals, a re-
sidual sACmRNAwas detected that encodes a protein containing the C2
domain and the remaining 140-kDa C-terminal region of full-length
sAC, although whether this C1-deleted protein has a function remains
unclear. Results obtained with the original C1-deleted mouse do show
that the C1 domain is necessary for some sAC physiologic functions, at
least in the testis, and are consistent with the observation from tmACs
that both C1 and C2 domains contribute to the active site required for
AC activity [54], but whether or not C1 and C2 domains are required
within the same protein for sAC activity is still an open question. The
sAC C1 and C2 domains are homologous to bacterial ACs, and within
bacteria these domains function in response to bicarbonate as individu-
al catalytic units [61], so sAC C2-only isoforms could also be catalytically
active on their own. It is also possible that C2-only sAC could either self-
associate or associate with catalytic domains of tmACs to reconstituteFig. 2. sAC is found in various neuronal compartments. sAC localization and activity have been d
and cell body.sAC activity in speciﬁc cell types. Studies conducted in Sf9 insect cells
seem to contradict the theory that C1- or C2-only sAC variants can
have catalytic function on their own, showing that only recombinant
derivatives of human sAC containing both C1 and C2 were capable of
adenylyl cyclase activity [64]. Whether sAC variants lacking catalytic
domains can restore physiologic cellular function with or without cata-
lytic activity remains an important question, for example as recently
studied in bronchial epithelial cells from C2-null transgenic animals
[85].
sAC is found in almost every mammalian tissue [62,64,86–88],
including neurons [89]. Within the cell, sAC localization and activity
are found in mitochondria, nuclei, and cytoplasmic compartments
including in axons, dendrites and growth cones (Fig. 2) [19,88–94].
However, despite ubiquitous sAC-related activity throughout various
tissues and organelles, there have been only 3 reported phenotypes
for the C1-deleted sAC transgenic mouse: infertility and dyslipidemia
[95], increased intraocular pressure [96], and altered insulin response
to glucose stimulation [97]. As there are 10 ACs in all with multiple
ACs expressed in every cell, deletion of a single cyclase may only
demonstrate a limited phenotype in certain cell conditions. Given
sAC's activation by bicarbonate, many sAC functions may only be
manifested in mice stressed pathologically as in ischemia, for example.
5. sAC in neurite outgrowth
What is the role of sAC in neurite outgrowth? sAC signaling associat-
ed neurite outgrowth appears to be regulated by neurotrophins. tmAC-
catalyzed cAMP production appears to operate via distinct signaling
pathways in synergy with NGF-dependent signaling, as demonstratedemonstrated in various neuronal compartments including the nucleus, axon, growth cone
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Rap1 activation for sustained Erk signaling, and sAC has been shown
to be necessary for NGF-mediated activation of Rap1 [98]. A role for
sAC in the signaling by TrkB ligands, BDNF and NT-4/5, is also support-
ed: for example, trafﬁcking and phosphorylation of TrkB have been
shown to be cAMP-dependent [36,99], and the same intrinsic growth
states associated with BDNF attraction by growth cones [100] have
been shown to increase neuronal survival and regeneration [101].
Using pharmacological inhibitors and siRNA against sAC, our lab has
recently demonstrated that sAC is necessary for retinal ganglion cell
(RGC) survival and axon growth [19]. These data also demonstrated
that other calcium-responsive tmACs, AC1 and AC8, were dispensable
for the survival and neurite outgrowth of RGCs in vitro, whereas reduc-
tion in sAC expression by siRNA or function by pharmacologic inhibition
signiﬁcantly reduced RGC survival and neurite growth [19]. Evidence
in support of a role for tmACs in neuronal survival and neurite out-
growth ismainly based on theuse of the tmAC activator, forskolin.How-
ever, forskolin is a strong tmAC agonist that could result in non-
physiological levels of cAMP that overwhelm normal intracellular
cAMP compartmentation. As a result, it is possible that forskolin stimu-
lation may not be representative of normal tmAC function in neurons.
Taken together, these data suggest that sAC is a critical AC controlling
cAMP-mediated intrinsic survival and neurite outgrowth properties of
neurons, at least in RGCs.
Additionally, a novel role for sAC has been recently documented in
the priming effect of BDNF on primary neurons which overcomesFig. 3. sAC has been linked to various neurotrophic signaling events in the growth cone. cAM
stimulated by PACAP, has been shown to be distinct from other neurotrophic signaling pathw
neurite outgrowth signaling via nerve growth factor (NGF). sAC also mediates neurite outgro
neuronal response to netrin binding to the deleted in colorectal cancer (DCC) receptor. Interesinhibition by CNS myelin [102]. In that paper it was shown that the
beneﬁt of BDNF pre-treatment was lost when sAC function was
disrupted via pharmacologic inhibition or genetic silencing. In addition
to this important role in BDNF-mediated neuronal ‘priming’, the authors
also demonstrated that sAC overexpression in the optic nerve enhanced
regeneration after optic nerve crush [102]. Itwaspreviously appreciated
that cAMP promotes regeneration, so the degree to which this effect is
speciﬁc to sAC or any other source of cAMP remains to be studied in
future work on sAC function in neuronal regeneration. Nevertheless
these data support the potential therapeutic utility of sAC activation in
promoting neurite growth in the CNS such as after spinal cord injury.
Besides neurotrophin-stimulated neurite outgrowth, sAC has also
been implicated in netrin-1 mediated growth cone guidance (Fig. 3).
Netrin-1 is released at the optic nerve head and attracts RGC axons
out of the eye into the optic nerve [15]. As RGCs age, their responsive-
ness to netrin-1 falls in associationwith a decline in cAMP. Interventions
which increase cAMP restore netrin-1 responsiveness in a manner sim-
ilar to the enhanced survival and neurite outgrowth of cAMP-rich im-
mature neurons [15]. In cultured dorsal root ganglion neurons,
attenuation of sAC function via pharmacologic inhibition or siRNA
caused a loss of netrin-1 responsiveness, while sAC overexpression
increased axonal extension and growth cone elaboration [103]. Interest-
ingly, no gross defect in axonal path-ﬁnding during development was
observed in the sAC C1 knock-out mouse [104]. These ﬁndings could
suggest that redundant or complementary mechanisms exist within
neurons for sAC function in vivo. However, defects in netrin-mediatedP production, and subsequent protein kinase A (PKA) activation, by tmACs such as that
ays. However, sAC-mediated production of cAMP has been shown to be important for the
wth and growth cone guidance mediated by netrin, and sAC function also increases the
tingly, both netrin and NGF cause localized inﬂux of calcium, which also activates sAC.
2565T.L. Stiles et al. / Biochimica et Biophysica Acta 1842 (2014) 2561–2568guidance may not have been detectable in the sAC C1 knock-out
mouse studies [104], as sAC's potential role may have yielded effects
that could be either too subtle for the assays employed, or conﬁned
to speciﬁc or untested neuronal subpopulations. As such, it is difﬁcult
to conclude a complete absence of disrupted axonal path-ﬁnding
solely from the assays utilized in this work [104]. Additionally, it
may also be possible that C1-deﬁcient sAC isoforms are readily
expressed and may somehow compensate for the loss of the C1
domain [73].
Besides being activated by bicarbonate, sAC is directly activated
by calcium independently of calmodulin [88,105]. Like cAMP,
calcium-dependent pathways play key roles in neuronal develop-
ment and function. Netrin-1 signaling also relies on calcium inﬂux
from intra- and extracellular sources for function [106], and NGF
induces intracellular calcium elevations [107]. As mentioned above,
calcium transients secondary to spontaneous electrical activity in
developing neurons affect in vivo axon extension and pathﬁnding
by growth cones [58]. Damaged mature neurons may not exhibit
the same spontaneous electrical activity, and this could explain a
decrease in cAMP observed after injury, although acutely there may
be other situations when there is an increase in calcium inﬂux after
injury [108]. That there was no decrease in survival and axonal
extension in RGCs from the double knockout of the calcium-
sensitive tmACs, AC1 and AC8, supports the hypothesis that sAC is
a primary contributor to the activity- and calcium-dependent eleva-
tion of cAMP and promotion of axon growth (Fig. 4) [19]. Finally, sAC
has also been shown to play a role in the nucleus-associated promo-
tion of neurite outgrowth, the transcriptional regulation needed for
sustained axonal extension, as sAC enhances CREB phosphorylation
(Fig. 5) [90].Fig. 4. Electrical activity leads to activation of sAC. Electrical activity in the axon leads to inﬂux, a
in intracellular cAMP, which activates PKA and promotes neurite outgrowth.6. Summary
Existing data show that sAC serves important functions in neuronal
survival and neurite extension. However, mechanistically little is
known regarding concerning sAC activity in these processes. While
sAC is thought to be associated with organelles such as the nucleus
and the mitochondrion, it is unknown whether these are relevant sites
of sAC action in neurons during development or injury. Future studies
evaluating the speciﬁc effects of sAC localization in different cellular
compartments may lend to a better understanding of the role of sAC
in these processes. In addition, how sAC is localized within cells is
unknown and whether sAC is associated with scaffold proteins such as
A-kinase anchoring proteins conferring sAC compartmentation requires
further investigation. cAMP effectors include PKA, Epac and cyclic nucle-
otide gated ion channels. With little exception, which of these targets
mediate sAC signals also has not been studied. sAC is unique among
the ACs in being regulated by bicarbonate and calcium and, as such, is
poised to play critical roles in neuronal disease and regeneration.
The inability of several studies to recapitulate effects in vivo of
genetic or pharmacologic disruption of sAC function in vitro, at least in
using currently available transgenic animals, is an obstacle to the
study of sAC moving forward. As the currently available transgenic
models only delete portions of the full-length protein, and only target
the C1 or C2 domains individually, it is difﬁcult to draw ﬁrm conclu-
sions. There is a clear need for more comprehensive knock-out and per-
haps knock-in models to better elucidate in vivo roles for this enzyme.
Similarly, although the discovery of sAC-speciﬁc pharmacologic inhibi-
tors has been invaluable, andmay also prove potentially therapeutically
useful, the lack of potent and speciﬁc pharmacological activators of sAC
could greatly aid in assessing the therapeutic potential for targeting sAC.nd intracellular release, of calciumwhich then directly activates sAC. This leads to increases
Fig. 5. sAC function leads to transcriptional changes in the nucleus. Nuclear-associated sAC responds to intracellular cues such as calcium and bicarbonate and leads to activation of CREB,
which leads to transcriptional changes that support sustained neurite outgrowth.
2566 T.L. Stiles et al. / Biochimica et Biophysica Acta 1842 (2014) 2561–2568Investigations into the mechanisms underlying sAC function are justi-
ﬁed by the functional data provided by several laboratories including
our own and should reveal novel strategies for manipulating sAC activ-
ity in beneﬁcial therapies.
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